Cape Investment Advisory’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $32.6K | Buy |
100
+10
| +11% | +$3.26K | 0.01% | 429 |
|
|
2025
Q1 | $24.3K | Hold |
90
| – | – | 0.01% | 444 |
|
|
2024
Q4 | $21.2K | Hold |
90
| – | – | 0.01% | 469 |
|
|
2024
Q3 | $24.8K | Hold |
90
| – | – | 0.01% | 421 |
|
|
2024
Q2 | $21.9K | Hold |
90
| – | – | 0.01% | 413 |
|
|
2024
Q1 | $13.5K | Hold |
90
| – | – | 0.01% | 490 |
|
|
2023
Q4 | $17.2K | Sell |
90
-3
| -3% | -$574 | 0.01% | 563 |
|
|
2023
Q3 | $16.5K | Hold |
93
| – | – | 0.01% | 476 |
|
|
2023
Q2 | $17.7K | Sell |
93
-3
| -3% | -$570 | 0.01% | 462 |
|
|
2023
Q1 | $19.2K | Buy |
+96
| New | +$19.2K | 0.01% | 428 |
|